当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析

尔康制药

(300267)

  

流通市值:44.95亿  总市值:65.18亿
流通股本:14.22亿   总股本:20.63亿

尔康制药(300267)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.27亿元,每股收益-0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益469834.93万元,未分配利润152211.07万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产539409.30万元,负债69574.37万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入854,289,240.97621,346,708.93275,789,340.21,783,118,780.92
营业总成本893,553,175.63626,817,368.29288,330,693.631,896,261,050.35
营业利润-20,299,504.0211,734,714.77838,832.93-206,725,851.98
利润总额-23,697,483.588,634,864.55748,003.27-198,932,851.03
净利润-26,889,704.76,338,336.65-285,701.09-221,853,783.74
其他综合收益-85,012,752.5-38,766,130.01-33,935,896.8828,889,756.85
综合收益总额-111,902,457.2-32,427,793.36-34,221,597.97-192,964,026.89
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,679,049,957.441,692,247,929.111,725,441,099.781,731,013,553.04
非流动资产合计3,715,043,022.423,735,765,705.583,736,415,852.723,748,055,304.7
资产总计5,394,092,979.865,428,013,634.695,461,856,952.55,479,068,857.74
流动负债合计626,942,140.73585,831,343.41620,227,763.04603,301,011.78
非流动负债合计68,801,548.9364,362,766.1665,752,659.5765,753,661.28
负债合计695,743,689.66650,194,109.57685,980,422.61669,054,673.06
归属于母公司股东权益合计4,725,838,323.34,803,778,905.964,805,081,554.794,836,045,778.17
股东权益合计4,698,349,290.24,777,819,525.124,775,876,529.894,810,014,184.68
负债和股东权益合计5,394,092,979.865,428,013,634.695,461,856,952.55,479,068,857.74
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计952,090,602.49677,520,811.61296,255,671.712,202,822,854.6
经营活动现金流出小计876,276,362.27549,891,834.96285,556,450.892,054,402,117.46
经营活动产生的现金流量净额75,814,240.22127,628,976.6510,699,220.82148,420,737.14
投资活动现金流入小计213,219,361.74152,090,828.86101,238,708.33866,268,986.76
投资活动现金流出小计474,507,107.01349,428,607.38301,873,254.89971,187,429.42
投资活动产生的现金流量净额-261,287,745.27-197,337,778.52-200,634,546.56-104,918,442.66
筹资活动现金流入小计507,700,000457,700,000307,844,027.78487,589,229.31
筹资活动现金流出小计369,526,492.94316,345,286.98152,957,168.49653,595,318.97
筹资活动产生的现金流量净额138,173,507.06141,354,713.02154,886,859.29-166,006,089.66
汇率变动对现金及现金等价物的影响-9,550,453.85-7,918,486.54-5,846,037.81201,122.18
现金及现金等价物净增加额-56,850,451.8463,727,424.61-40,894,504.26-122,302,673
期末现金及现金等价物余额453,787,274.52574,365,150.97469,743,222.1510,637,726.36
TOP↑